华绿生物
(300970)
| 流通市值：16.37亿 | | | 总市值：21.10亿 |
| 流通股本：9513.61万 | | | 总股本：1.23亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 867,669,135 | 498,535,994.34 | 270,596,190.27 | 1,032,111,560.17 |
| 营业收入 | 867,669,135 | 498,535,994.34 | 270,596,190.27 | 1,032,111,560.17 |
| 二、营业总成本 | 858,235,706.04 | 560,076,558.51 | 271,307,730.48 | 1,072,414,292.17 |
| 营业成本 | 790,102,924.63 | 515,402,873.64 | 250,582,924.99 | 970,609,145.98 |
| 税金及附加 | 522,799.82 | 329,368.39 | 153,128.04 | 757,423.61 |
| 销售费用 | 6,634,235.19 | 4,497,720.29 | 2,233,467.51 | 10,829,040.29 |
| 管理费用 | 44,033,748.63 | 30,381,317.32 | 14,602,620.5 | 67,674,468.18 |
| 研发费用 | 11,369,406.35 | 5,970,951.72 | 1,880,483.78 | 14,605,198.13 |
| 财务费用 | 5,572,591.42 | 3,494,327.15 | 1,855,105.66 | 7,939,015.98 |
| 其中:利息费用 | 11,302,821.01 | 7,400,329.49 | - | 11,184,462.3 |
| 其中:利息收入 | 5,753,565.86 | 3,924,982.95 | - | 3,282,699.92 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 0 | - | - | 86,571.69 |
| 资产处置收益 | -438,905.09 | -269,291.73 | -109,668.96 | -1,483,161.95 |
| 资产减值损失(新) | -699,213.55 | -670,756.49 | -9,270.98 | -11,948,029.48 |
| 信用减值损失(新) | 143,613.37 | 143,613.37 | - | -1,905,786.2 |
| 其他收益 | 8,504,609.2 | 5,359,937.43 | 2,914,374.55 | 11,466,924.82 |
| 四、营业利润 | 16,943,532.89 | -56,977,061.59 | 2,083,894.4 | -44,086,213.12 |
| 加:营业外收入 | 373,579.1 | 202,119.63 | 63,241.76 | 541,714.77 |
| 减:营业外支出 | 464,686.3 | 198,188.42 | 182,850.79 | 733,792.69 |
| 五、利润总额 | 16,852,425.69 | -56,973,130.38 | 1,964,285.37 | -44,278,291.04 |
| 减:所得税费用 | 8,555.2 | -44.8 | - | 145,140.46 |
| 六、净利润 | 16,843,870.49 | -56,973,085.58 | 1,964,285.37 | -44,423,431.5 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | - | -56,973,085.58 | - | -44,423,431.5 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 16,333,517.64 | -53,694,652.84 | 1,544,654.24 | -47,565,525.06 |
| 少数股东损益 | 510,352.85 | -3,278,432.74 | 419,631.13 | 3,142,093.56 |
| 扣除非经常损益后的净利润 | 15,529,540.25 | -54,208,168.34 | 1,128,975.92 | -48,483,877.11 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.14 | -0.45 | 0.01 | -0.41 |
| (二)稀释每股收益 | 0.14 | -0.45 | 0.01 | -0.41 |
| 九、综合收益总额 | 16,843,870.49 | -56,973,085.58 | 1,964,285.37 | -44,423,431.5 |
| 归属于母公司股东的综合收益总额 | 16,333,517.64 | -53,694,652.84 | 1,544,654.24 | -47,565,525.06 |
| 归属于少数股东的综合收益总额 | 510,352.85 | -3,278,432.74 | 419,631.13 | 3,142,093.56 |
| 公告日期 | 2025-10-24 | 2025-08-27 | 2025-04-24 | 2025-04-24 |
| 审计意见(境内) | | | | 标准无保留意见 |